Phase IV News
Most Popular Phase IV Story
Galderma buys CollaGenex in $420M deal
A subsidiary of Galderma Pharma will buy CollaGenex Pharmaceuticals--which makes Oracea for Read more...
Latest Headlines
- February 26, 2008
- September 26, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
